Your browser doesn't support javascript.
loading
Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs).
Cooper, Bethany M; Iegre, Jessica; O' Donovan, Daniel H; Ölwegård Halvarsson, Maria; Spring, David R.
Afiliação
  • Cooper BM; Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. spring@ch.cam.ac.uk.
  • Iegre J; Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. spring@ch.cam.ac.uk.
  • O' Donovan DH; Oncology R&D, AstraZeneca, Cambridge, CB4 0WG, UK.
  • Ölwegård Halvarsson M; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Spring DR; Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. spring@ch.cam.ac.uk.
Chem Soc Rev ; 50(3): 1480-1494, 2021 Feb 15.
Article em En | MEDLINE | ID: mdl-33346298
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Portadores de Fármacos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Portadores de Fármacos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article